AbbVie saw the highest growth of 137% in patent filings in January and 126% in grants in February in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 137% and grants by 89%. GlobalData’s DataBook provides a comprehensive analysis of AbbVie‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

AbbVie has been focused on protecting inventions in United States(US) with 61 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 26% filings and 20% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and Australia(AU) patent Office are among the top ten patent offices where AbbVie is filings its patents. Among the top granted patent authorities, AbbVie has 20% of its grants in United States(US), 14% in Israel(IL) and 9% in European Patent Office(EPO).

F. Hoffmann-La Roche could be the strongest competitor for AbbVie

In terms of grant share, AbbVie stands in seventh position among its competitors. AbbVie and F. Hoffmann-La Roche secured the top positions according to recent patent publication data.

Patents related to rare diseases and climate change lead AbbVie's portfolio

AbbVie has the highest number of patents in rare diseases followed by, climate change and cell & gene therapy. For rare diseases, nearly 51% of patents were filed and 56% of patents were granted in Q1 2024.

General surgery devices related patents lead AbbVie portfolio followed by ophthalmic devices, and preleukemia

AbbVie has highest number of patents in general surgery devices followed by ophthalmic devices, preleukemia, lymphoma, and ileitis. For general surgery devices, nearly 1% of patents were filed and 3% of patents were granted in Q1 2024.

For comprehensive analysis of AbbVie's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.